Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, Third Edition, POCT12A3E
standard by Clinical and Laboratory Standards Institute, 01/01/2013
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,
Determination of Factor Coagulant Activities; Approved Guideline
standard by Clinical and Laboratory Standards Institute, 04/01/1997
Molecular Diagnostic Methods for Infectious Diseases; MM03Ed3E
standard by Clinical and Laboratory Standards Institute, 02/01/2015
Quality Management System: Continual Improvement; Approved Guideline – Third Edition, QMS06A3E
standard by Clinical and Laboratory Standards Institute, 06/01/2011
IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard, AUTO11A2E
standard by Clinical and Laboratory Standards Institute, 10/01/2014
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2011
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; 4th Edition M23Ed4E
standard by Clinical and Laboratory Standards Institute, 01/01/2016
User Evaluation of Between-Reagent Lot Variation; Approved Guideline, EP26AE
standard by Clinical and Laboratory Standards Institute, 09/01/2013
Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline (formerly I/LA31-A), NBS03AE
standard by Clinical and Laboratory Standards Institute,
Validation, Verification, and Quality Assurance of Automated Hematology Analyzers; Approved Standard-Second Edition, H26A2
standard by Clinical and Laboratory Standards Institute, 01/01/2010